Effect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes Mellitus
Status:
Completed
Trial end date:
2016-08-05
Target enrollment:
Participant gender:
Summary
This study is designed to investigate the clinical efficacy and safety of pramlintide
co-administered as a fixed-dose ratio with basal-bolus SC insulin, delivered simultaneously
via 2 separate pumps, in subjects with type 1 diabetes who are failing to achieve the desired
level of glycemic control using insulin therapy.